Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events
Conclusion
We found no difference between varenicline and prescription NRT patches in the risk of recurrent MACE. These results should be considered when determining the most appropriate choice of smoking cessation pharmacotherapy.
Source: Heart - Category: Cardiology Authors: Robijn, A. L., Filion, K. B., Woodward, M., Hsu, B., Chow, C. K., Pearson, S.-A., Jorm, L., Falster, M. O., Havard, A. Tags: Cardiac risk factors and prevention Source Type: research
More News: Australia Health | Cardiology | Cardiovascular | Chantix | Heart | Nicotine | Nicotine Replacement Therapy | Smokers | Study | Wales Health